1040785

Nesher Pharmaceuticals (USA) LLC — FEI 1922352

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 11, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bridgeton, MO (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)